yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q24244161-26E4311A-693C-41E4-89B2-C0D67078A6D0
Q24244161-26E4311A-693C-41E4-89B2-C0D67078A6D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24244161-26E4311A-693C-41E4-89B2-C0D67078A6D0
Bisphosphonates for advanced prostate cancer
P2860
Q24244161-26E4311A-693C-41E4-89B2-C0D67078A6D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24244161-26E4311A-693C-41E4-89B2-C0D67078A6D0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d4f7497b549fd0162d084780104af22bc300150b
P2860
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain.